L12.31 Epidermolysis bullosa due to drug
Instructional Notes:
-
L12.31
Description: Epidermolysis bullosa due to drug
Use Additional Code:
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
↓
-
L12.3
Description: Acquired epidermolysis bullosa
Exclude1:
- epidermolysis bullosa (congenital) (Q81.-)
↓
-
L12
Description: Pemphigoid
Exclude1:
- herpes gestationis (O26.4-)
- impetigo herpetiformis (L40.1)
↓
-
L10-L14
Description: Bullous disorders (L10-L14)
Exclude1:
- benign familial pemphigus [Hailey-Hailey] (Q82.8)
- staphylococcal scalded skin syndrome (L00)
- toxic epidermal necrolysis [Lyell] (L51.2)
↓
-
L00-L99
Description: Diseases of the skin and subcutaneous tissue
Exclude2:
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- lipomelanotic reticulosis (I89.8)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- systemic connective tissue disorders (M30-M36)
- viral warts (B07.-)